Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Link
http://link.springer.com/article/10.1007/s13318-016-0371-0/fulltext.html
Reference27 articles.
1. Song S, Matsushima N, Lee J, Mendell J. Linear mixed-effect model of QTc prolongation for Olmesartan medoxomil. J Clin Pharmacol. 2016;56:96–100.
2. Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacrooute J, Skinazi F, Mesnard B, Chayvialle JA, Savoye G, Druez A, Parlier D, Abitbol V, Gompel M, Eoche M, Poncin E, Bobichon R, Colardelle P, Wils P, Salloum H, Peschard S, Zerbib F, Méresse B, Cerf-Bensussan N, Malamut G, Carbonnel F. Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther. 2014;40:1103–9.
3. Scott LJ, McCormack PL. Olmesartan medoxomil: a review of its use in the management of hypertension. Drugs. 2008;68:1239–72.
4. Lee J, Kim A, Yu K, Chung J, Yim S, Kim B. Pharmacokinetics and bioequivalence of two different 20 mg olmesartan tablets: a randomized, single-dose, two-period crossover study in healthy Korean male volunteers. Transl Clin Pharmacol. 2015;23:49–53.
5. Muir VJ, Keating GM. Olmesartan medoxomil in children and adolescents with hypertension. Drugs. 2010;70:2439–47.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of angiotensin receptor blockers in the context of Alzheimer's disease;Fundamental & Clinical Pharmacology;2023-01-26
2. Mathematical models for biomarker calculation of drug-induced liver injury in humans and experimental models based on gadoxetate enhanced magnetic resonance imaging;PLOS ONE;2023-01-06
3. Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2022-10-26
4. Identification and characterization of higenamine metabolites in human urine by quadrupole-orbitrap LC-MS/MS for doping control;Journal of Pharmaceutical and Biomedical Analysis;2022-05
5. NEPHROPROTECTIVE EFFECT OF OLMESARTAN ON RENAL ISCHEMIA REPERFUSION INJURY IN MALE RATS: THE ROLE OF NRF2/HO-1 SIGNALING PATHWAY;Wiadomości Lekarskie;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3